Search

Brian A. Whiteman

Examiner (ID: 16463, Phone: (571)272-0764 , Office: P/1674 )

Most Active Art Unit
1635
Art Unit(s)
1635, 1636, 1633, 1674
Total Applications
1739
Issued Applications
920
Pending Applications
243
Abandoned Applications
617

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18297965 [patent_doc_number] => 20230107651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => METHODS OF TREATING SPINAL MUSCULAR ATROPHY [patent_app_type] => utility [patent_app_number] => 17/819742 [patent_app_country] => US [patent_app_date] => 2022-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24993 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17819742 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/819742
METHODS OF TREATING SPINAL MUSCULAR ATROPHY Aug 14, 2022 Abandoned
Array ( [id] => 18058340 [patent_doc_number] => 20220389426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => miRNA AS BIOMARKER FOR PARKINSON'S DISEASE AND DIAGNOSTIC KIT USING SAME [patent_app_type] => utility [patent_app_number] => 17/888084 [patent_app_country] => US [patent_app_date] => 2022-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7563 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17888084 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/888084
miRNA AS BIOMARKER FOR PARKINSON'S DISEASE AND DIAGNOSTIC KIT USING SAME Aug 14, 2022 Abandoned
Array ( [id] => 18389840 [patent_doc_number] => 20230158058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING A BLEEDING EVENT IN A SUBJECT HAVING HEMOPHILIA [patent_app_type] => utility [patent_app_number] => 17/878884 [patent_app_country] => US [patent_app_date] => 2022-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54778 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17878884 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/878884
METHODS AND COMPOSITIONS FOR TREATING A BLEEDING EVENT IN A SUBJECT HAVING HEMOPHILIA Jul 31, 2022 Pending
Array ( [id] => 18420525 [patent_doc_number] => 20230174987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => Modulation of Dystrophia Myotonica-Protein Kinase (DMPK) Expression [patent_app_type] => utility [patent_app_number] => 17/814120 [patent_app_country] => US [patent_app_date] => 2022-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39524 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17814120 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/814120
Modulation of dystrophia myotonica-protein kinase (DMPK) expression Jul 20, 2022 Issued
Array ( [id] => 19930332 [patent_doc_number] => 12303525 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-05-20 [patent_title] => Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection [patent_app_type] => utility [patent_app_number] => 17/813576 [patent_app_country] => US [patent_app_date] => 2022-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 28 [patent_no_of_words] => 43142 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17813576 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/813576
Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection Jul 18, 2022 Issued
Array ( [id] => 18196503 [patent_doc_number] => 20230050022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-16 [patent_title] => COMPOSITIONS AND METHODS RELATED TO TRANSFERRIN RECEPTOR-BINDING APTAMERS [patent_app_type] => utility [patent_app_number] => 17/813021 [patent_app_country] => US [patent_app_date] => 2022-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45795 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17813021 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/813021
COMPOSITIONS AND METHODS RELATED TO TRANSFERRIN RECEPTOR-BINDING APTAMERS Jul 14, 2022 Pending
Array ( [id] => 18466962 [patent_doc_number] => 20230201242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => RIG-I AGONISTS AND METHODS USING SAME [patent_app_type] => utility [patent_app_number] => 17/864199 [patent_app_country] => US [patent_app_date] => 2022-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29192 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17864199 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/864199
RIG-I AGONISTS AND METHODS USING SAME Jul 12, 2022 Abandoned
Array ( [id] => 18895550 [patent_doc_number] => 20240011035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => METHODS RELATING TO CIRCULATING TUMOR CELL CLUSTERS AND THE TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 17/863984 [patent_app_country] => US [patent_app_date] => 2022-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37794 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17863984 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/863984
METHODS RELATING TO CIRCULATING TUMOR CELL CLUSTERS AND THE TREATMENT OF CANCER Jul 12, 2022 Abandoned
Array ( [id] => 18530264 [patent_doc_number] => 20230235334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-27 [patent_title] => PHOSPHORYLATION-BASED MIRNA SENSOR [patent_app_type] => utility [patent_app_number] => 17/811593 [patent_app_country] => US [patent_app_date] => 2022-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19477 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17811593 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/811593
Phosphorylation-based miRNA sensor Jul 10, 2022 Issued
Array ( [id] => 18345814 [patent_doc_number] => 20230133924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => OPTIMIZED EXPRESSION CASSETTES FOR GENE THERAPY [patent_app_type] => utility [patent_app_number] => 17/811549 [patent_app_country] => US [patent_app_date] => 2022-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51684 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -100 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17811549 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/811549
OPTIMIZED EXPRESSION CASSETTES FOR GENE THERAPY Jul 7, 2022 Pending
Array ( [id] => 18077783 [patent_doc_number] => 20220403395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-22 [patent_title] => COMPOSITION FOR INHIBITING GROWTH OF CANCER STEM CELLS, CONTAINING WDR34 INHIBITOR, AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/851500 [patent_app_country] => US [patent_app_date] => 2022-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8388 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17851500 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/851500
COMPOSITION FOR INHIBITING GROWTH OF CANCER STEM CELLS, CONTAINING WDR34 INHIBITOR, AND USE THEREOF Jun 27, 2022 Pending
Array ( [id] => 18226726 [patent_doc_number] => 20230065720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => High Throughput Cell-Based Screening for Aptamers [patent_app_type] => utility [patent_app_number] => 17/809043 [patent_app_country] => US [patent_app_date] => 2022-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14490 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17809043 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/809043
High Throughput Cell-Based Screening for Aptamers Jun 26, 2022 Abandoned
Array ( [id] => 19915227 [patent_doc_number] => 12290573 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-05-06 [patent_title] => Modified RNAi agents [patent_app_type] => utility [patent_app_number] => 17/848850 [patent_app_country] => US [patent_app_date] => 2022-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26130 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 219 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17848850 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/848850
Modified RNAi agents Jun 23, 2022 Issued
Array ( [id] => 17990437 [patent_doc_number] => 20220356474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-10 [patent_title] => NUCLEIC ACID, COMPOSITION AND CONJUGATE COMPRISING THE SAME, PREPARATION METHOD AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/847770 [patent_app_country] => US [patent_app_date] => 2022-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46551 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17847770 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/847770
Nucleic acid, composition and conjugate comprising the same, preparation method and use thereof Jun 22, 2022 Issued
Array ( [id] => 18058337 [patent_doc_number] => 20220389423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => Compositions and Methods for Simultaneously Modulating Expression of Genes [patent_app_type] => utility [patent_app_number] => 17/846288 [patent_app_country] => US [patent_app_date] => 2022-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 88637 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17846288 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/846288
Compositions and Methods for Simultaneously Modulating Expression of Genes Jun 21, 2022 Pending
Array ( [id] => 18226046 [patent_doc_number] => 20230065040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => SUBCUTANEOUS DELIVERY OF MESSENGER RNA [patent_app_type] => utility [patent_app_number] => 17/841194 [patent_app_country] => US [patent_app_date] => 2022-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17355 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17841194 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/841194
SUBCUTANEOUS DELIVERY OF MESSENGER RNA Jun 14, 2022 Pending
Array ( [id] => 19701719 [patent_doc_number] => 12195734 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-01-14 [patent_title] => Deaminase-based RNA sensors [patent_app_type] => utility [patent_app_number] => 17/806879 [patent_app_country] => US [patent_app_date] => 2022-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 111 [patent_figures_cnt] => 168 [patent_no_of_words] => 22384 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17806879 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/806879
Deaminase-based RNA sensors Jun 13, 2022 Issued
17/769384 METHOD FOR PREPARING CELL-FREE PROTEIN EXPRESSION GEL USING PLASMID Jun 12, 2022 Abandoned
Array ( [id] => 18286356 [patent_doc_number] => 20230101828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => KISSPEPTIN 1 (KISS1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/837479 [patent_app_country] => US [patent_app_date] => 2022-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58063 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17837479 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/837479
KISSPEPTIN 1 (KISS1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF Jun 9, 2022 Abandoned
Array ( [id] => 18123928 [patent_doc_number] => 20230009539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-12 [patent_title] => SBE APTAMERS FOR TREATING IL-17a RELATED DISEASES AND CONDITIONS [patent_app_type] => utility [patent_app_number] => 17/833323 [patent_app_country] => US [patent_app_date] => 2022-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17026 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17833323 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/833323
SBE APTAMERS FOR TREATING IL-17a RELATED DISEASES AND CONDITIONS Jun 5, 2022 Pending
Menu